NT
Niketa Tyagi
About Niketa Tyagi
Data last updated:
Niketa Tyagi is a Director at Uniplus Biotech Private Limited (since 2019), Director at Bestopick Life Sciences Private Limited (since 2021) and Director at Omex Biotech Private Limited (since 2019). The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹3.95 Cr; the largest is Uniplus Biotech Private Limited at ₹3.64 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Uniplus Biotech Private Limited U24233UP2010PTC039322 | Director | 10 Jun 2019 | 2010 | ₹3.64 Cr (FY 2024) | Active |
| Bestopick Life Sciences Private Limited U24233UP2010PTC039426 | Director | 11 Jun 2021 | 2010 | ₹28.5 Lakh (FY 2024) | Active |
| Omex Biotech Private Limited U24110DL2007PTC170203 | Director | 21 Aug 2019 | 2007 | ₹2.7 Lakh (FY 2023) | Active |
Board colleagues of Niketa Tyagi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suman Lata | 03099374 | Uniplus Biotech Private Limited , Bestopick Life Sciences Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Niketa Tyagi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niketa Tyagi
Niketa Tyagi currently holds 3 directorships: Uniplus Biotech Private Limited (Director, since 10 Jun 2019, revenue ₹3.64 Cr (FY 2024)); Bestopick Life Sciences Private Limited (Director, since 11 Jun 2021, revenue ₹28.5 Lakh (FY 2024)); Omex Biotech Private Limited (Director, since 21 Aug 2019, revenue ₹2.7 Lakh (FY 2023)).
Niketa Tyagi was first appointed on 10 Jun 2019 as Director at Uniplus Biotech Private Limited. The most recent appointment on record is 11 Jun 2021 at Bestopick Life Sciences Private Limited.
The 3 current companies of Niketa Tyagi that report revenue have a combined latest revenue of ₹3.95 Cr: Uniplus Biotech Private Limited ₹3.64 Cr (FY 2024); Bestopick Life Sciences Private Limited ₹28.5 Lakh (FY 2024); Omex Biotech Private Limited ₹2.7 Lakh (FY 2023).
The current boards of Niketa Tyagi's companies include Suman Lata (Uniplus Biotech Private Limited).